← Browse by Condition
Medical Condition
brain tumor recurrent
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT02800486 Phase 2
Recruiting
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Enrollment
37 pts
Location
United States
Sponsor
Northwell Health
NCT06496971 Phase 3
Recruiting
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Enrollment
32 pts
Location
Taiwan
Sponsor
NaviFUS Corporation
NCT05629702 Phase 2
Recruiting
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Enrollment
120 pts
Location
United Kingdom
Sponsor
University of Birmingham